Role of organic cation transporter 3 (SLC22A3) and its missense variants in the pharmacologic action of metformin

被引:164
作者
Chen, Ligong [1 ]
Pawlikowski, Bradley [2 ]
Schlessinger, Avner [1 ]
More, Swati S. [1 ]
Stryke, Doug [3 ]
Johns, Susan J. [3 ]
Portman, Michael A. [1 ]
Chen, Eugene [1 ]
Ferrin, Thomas E. [3 ]
Sali, Andrej [1 ]
Giacomini, Kathleen M. [1 ]
机构
[1] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94158 USA
[2] Univ Calif San Francisco, Dept Cell & Tissue Biol, San Francisco, CA 94158 USA
[3] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA
基金
美国国家卫生研究院;
关键词
metformin; monoamines; muscle cells; organic cation transporters; pharmacogenomics; ACTIVATED PROTEIN-KINASE; TOXIN EXTRUSION 1; GENETIC-VARIATION; RISK LOCUS; OCT1; POLYMORPHISMS; MULTIDRUG; MECHANISM; ASSOCIATION; EXPRESSION;
D O I
10.1097/FPC.0b013e32833fe789
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Objectives The goals of this study were to determine the role of organic cation transporter 3 (OCT3) in the pharmacological action of metformin and to identify and functionally characterize genetic variants of OCT3 with respect to the uptake of metformin and monoamines. Methods For pharmacological studies, we evaluated metformin-induced activation of AMP-activated protein kinase, a molecular target of metformin. We used quantitative PCR and immunostaining to localize the transporter and isotopic uptake studies in cells transfected with OCT3 and its nonsynonymous genetic variants for functional analyses. Results Quantitative PCR and immunostaining showed that OCT3 was expressed high on the plasma membrane of skeletal muscle and liver, target tissues for metformin action. Both the OCT inhibitor, cimetidine, and OCT3-specific short hairpin RNA significantly reduced the activating effect of metformin on AMP-activated protein kinase. To identify genetic variants in OCT3, we used recent data from the 1000 Genomes and the Pharmacogenomics of Membrane Transporters projects. Six novel missense variants were identified. In functional assays, using various monoamines and metformin, three variants, T44M (c.131C > T), T400I (c.1199C > T) and V423F (c.1267G > T) showed altered substrate specificity. Notably, in cells expressing T400I and V423F, the uptakes of metformin and catecholamines were significantly reduced, but the uptakes of metformin, 1-methyl-4-phenylpyridinium and histamine by T44M were significantly increased more than 50%. Structural modeling suggested that these two variants may be located in the pore lining (T400) or proximal (V423) membrane-spanning helixes. Conclusion Our study suggests that OCT3 plays a role in the therapeutic action of metformin and that genetic variants of OCT3 may modulate metformin and catecholamine action. Pharmacogenetics and Genomics 20:687-699 (C) 2010 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.
引用
收藏
页码:687 / 699
页数:13
相关论文
共 44 条
  • [1] Stimulation of AMP-activated protein kinase (AMPK) is associated with enhancement of Glut1-mediated glucose transport
    Abbud, W
    Habinowski, S
    Zhang, JZ
    Kendrew, J
    Elkairi, FS
    Kemp, BE
    Witters, LA
    Ismail-Beigi, F
    [J]. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2000, 380 (02) : 347 - 352
  • [2] Structure and mechanism of the lactose permease of Escherichia coli
    Abramson, J
    Smirnova, I
    Kasho, V
    Verner, G
    Kaback, HR
    Iwata, S
    [J]. SCIENCE, 2003, 301 (5633) : 610 - 615
  • [3] Non-insulin therapies for type 2 diabetes
    Ashiya, Mona
    Smith, Richard E. T.
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2007, 6 (10) : 777 - 778
  • [4] Organic cation transporter 3: Keeping the brake on extracellular serotonin in serotonin-transporter-deficient mice
    Baganz, Nicole L.
    Horton, Rebecca E.
    Calderon, Alfredo S.
    Owens, W. Anthony
    Munn, Jaclyn L.
    Watts, Lora T.
    Koldzic-Zivanovic, Nina
    Jeske, Nathaniel A.
    Koek, Wouter
    Toney, Glenn M.
    Daws, Lynette C.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (48) : 18976 - 18981
  • [5] Genetic variation in the organic cation transporter 1 is associated with metformin response in patients with diabetes mellitus
    Becker, M. L.
    Visser, L. E.
    van Schaik, R. H. N.
    Hofman, A.
    Uitterlinden, A. G.
    Stricker, B. H. C.
    [J]. PHARMACOGENOMICS JOURNAL, 2009, 9 (04) : 242 - 247
  • [6] Genetic Variation in the Multidrug and Toxin Extrusion 1 Transporter Protein Influences the Glucose-Lowering Effect of Metformin in Patients With Diabetes: A Preliminary Study
    Becker, Matth S. L.
    Visser, Loes E.
    van Schaik, Ron H. N.
    Hofman, Albert
    Uitterlinden, Andre G.
    Stricker, Bruno H. Ch.
    [J]. DIABETES, 2009, 58 (03) : 745 - 749
  • [7] Interaction between polymorphisms in the OCT1 and MATE1 transporter and metformin response
    Becker, Matthijs L.
    Visser, Loes E.
    van Schaik, Ron H. N.
    Hofman, Albert
    Uitterlinden, Andre G.
    Stricker, Bruno H. Ch.
    [J]. PHARMACOGENETICS AND GENOMICS, 2010, 20 (01) : 38 - 44
  • [8] Exploring the extremes of sequence/structure space with ensemble fold recognition in the program Phyre
    Bennett-Lovsey, Riccardo M.
    Herbert, Alex D.
    Sternberg, Michael J. E.
    Kelley, Lawrence A.
    [J]. PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2008, 70 (03) : 611 - 625
  • [9] Expression profiles of 50 xenobiotic transporter genes in humans and pre-clinical species: A resource for investigations into drug disposition
    Bleasby, K.
    Castle, J. C.
    Roberts, C. J.
    Cheng, C.
    Bailey, W. J.
    Sina, J. F.
    Kulkarni, A. V.
    Hafey, M. J.
    Evers, R.
    Johnson, J. M.
    Ulrich, R. G.
    Slatter, J. G.
    [J]. XENOBIOTICA, 2006, 36 (10-11) : 963 - 988
  • [10] Effect of genetic variation in the organic cation transporter 2 on the renal elimination of metformin
    Chen, Ying
    Li, Shuanglian
    Brown, Chaline
    Cheatham, Stephen
    Castro, Richard A.
    Leabman, Maya K.
    Urban, Thomas J.
    Chen, Ligong
    Yee, Sook Wah
    Choi, Ji Ha
    Huang, Yong
    Brett, Claire M.
    Burchard, Esteban G.
    Giacomini, Kathleen M.
    [J]. PHARMACOGENETICS AND GENOMICS, 2009, 19 (07) : 497 - 504